1. Home
  2. ACRV vs HDSN Comparison

ACRV vs HDSN Comparison

Compare ACRV & HDSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acrivon Therapeutics Inc.

ACRV

Acrivon Therapeutics Inc.

HOLD

Current Price

$2.37

Market Cap

82.7M

Sector

Health Care

ML Signal

HOLD

Logo Hudson Technologies Inc.

HDSN

Hudson Technologies Inc.

HOLD

Current Price

$6.97

Market Cap

409.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACRV
HDSN
Founded
2018
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
82.7M
409.2M
IPO Year
2022
1994

Fundamental Metrics

Financial Performance
Metric
ACRV
HDSN
Price
$2.37
$6.97
Analyst Decision
Buy
Strong Buy
Analyst Count
5
2
Target Price
$14.67
$9.50
AVG Volume (30 Days)
454.7K
463.3K
Earning Date
11-13-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.50
Revenue
N/A
$236,847,000.00
Revenue This Year
N/A
$2.65
Revenue Next Year
$805.20
$3.69
P/E Ratio
N/A
$13.85
Revenue Growth
N/A
N/A
52 Week Low
$1.05
$5.11
52 Week High
$8.00
$10.52

Technical Indicators

Market Signals
Indicator
ACRV
HDSN
Relative Strength Index (RSI) 52.73 40.34
Support Level $2.12 $6.81
Resistance Level $2.44 $7.53
Average True Range (ATR) 0.19 0.27
MACD -0.03 0.00
Stochastic Oscillator 44.26 17.24

Price Performance

Historical Comparison
ACRV
HDSN

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About HDSN Hudson Technologies Inc.

Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.

Share on Social Networks: